Indication
Gastric reflux, heartburn, flatulence associated with gastric reflux, heartburn of
pregnancy, all cases of epigastric and retrosternal distress were the underlying cause
is gastric reflux.
Dosage & Administration
For oral administration. Adult and children over 12 years: 10-20 ml after meals and at
bedtime, up to four times a day. Children 6 to 12 years: 5-10 ml after meals and at
bedtime, up to four times a day. Children under 6 years: Not recommended. Elderly: No
dosage modification is required for this age group.
Precautions
If symptoms do not improve after 7 days, the clinical situation should be reviewed.
Each 10 ml dose has a Sodium content of 141 mg (6.2 mmol). This should be taken
into account when a highly restricted salt diet is recommended. e.g in some cases of
congestive cardiac failure and renal impairment. Each 10 ml dose contains 160 mg
(1.6 mmol) of Calcium Carbonate. Care needs to be taken in treating patients with
hypercalcemia. nephrocalcinosis and recurrent calcium containing renal calculi.
Use in Pregnancy and Lactation
Clinical studies in more than 500 pregnant women as well as a large amount of data
from post-marketing experience indicate no malformative nor feto/neonatal toxicity of
the active ingredients. This drug can be used during pregnancy, if clinically needed. No
effects of the active substances have been shown in breastfed newborns/infants of
treated mothers. This drug can be used during breast-feeding.
Fertility: Pre-clinical investigations have revealed Alginate has no negative effect on
parental or offspring fertility or reproduction. Clinical data do not suggest that this drug
has an effect on human fertility.
